TNPOF yields 13.97% · PFE yields 6.13%● Live data
📍 TNPOF pulled ahead of the other in Year 1
Combined, TNPOF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TNPOF + PFE for your $10,000?
Ten Pao Group Holdings Limited, an investment holding company, develops, manufactures, and sells electric charging products in the People's Republic of China, the rest of Asia, the United States, Europe, Africa, and internationally. It operates through six segments: Telecommunication, Media and Entertainment, Electrical Home Appliances, Lighting, Smart Chargers and Controllers, and Others. The company offers switching power supply units, such as quick chargers, wireless chargers, and adapters; LED power supply products; electric vehicle chargers; switched-mode power supply units; power tools; power inverters; and other power supply solutions for clients in the security, industrial automation and control system, machinery, electrical equipment, and communication applications. It is also involved in trading audio devices, substation cabinets, and power supply devices and raw materials. In addition, the company provides building decoration services. Ten Pao Group Holdings Limited was founded in 1979 and is headquartered in Kwun Tong, Hong Kong.
Full TNPOF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.